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Abstract Developed societies, although having successfully
reduced the burden of infectious disease, constitute an envi-
ronment where metabolic, cardiovascular, and autoimmune
diseases thrive. Living in westernized countries has not fun-
damentally changed the genetic basis on which these diseases
emerge, but has strong impact on lifestyle and pathogen
exposure. In particular, nutritional patterns collectively termed
the “Western diet”, including high-fat and cholesterol, high-
protein, high-sugar, and excess salt intake, as well as frequent
consumption of processed and ‘fast foods’, promote obesity,
metabolic syndrome, and cardiovascular disease. These fac-
tors have also gained high interest as possible promoters of
autoimmune diseases. Underlying metabolic and immunolog-
ic mechanisms are currently being intensively explored. This
review discusses the current knowledge relative to the associ-
ation of “Western diet” with autoimmunity, and highlights the
role of T cells as central players linking dietary influences to
autoimmune pathology.
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Introduction
Autoimmune diseases such as multiple sclerosis (MS), rheu-
matoid arthritis (RA), inflammatory bowel disease (IBD), type
1 diabetes (T1D), and psoriasis (Ps) are a heterogeneous set of
diseases that share common hallmarks including multifactori-
al aetiologies, involvement of T cell-mediated autoimmune
pathomechanisms, and a chronic clinical course that often
requires life-long disease management. Genetic factors clearly
predispose to the development of inflammatory autoimmune
diseases [1•, 2], but a relatively low concordance rate for most
of the diseases between monozygotic twins [3] suggests envi-
ronmental factors as important triggers of disease. This view is
corroborated by the striking increase of autoimmune diseases
in recent decades, whereas the genetic basis in affected pop-
ulations has remained arguably constant [4]. Notably, there is
a high prevalence in Western societies and established market
economies as opposed to a lower prevalence in the Eastern
world and developing countries [4, 5]. It is of interest that
there are also some high prevalence areas today that display a
stable or even slightly declining occurrence of some autoim-
mune diseases [6, 7], while there is certainly a steep incline in
former low prevalence regions [8–11]. The trend towards a
higher prevalence often coincides with a high pace of socio-
economic improvement and westernization in these countries
[4, 5]. There are multiple explanations of how the “Western
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lifestyle” favors the development of autoimmunity. The hy-
giene hypothesis states that high standards of hygiene and
good health care reduce the burden of infections, but can also
limit exposure to pathogens that are potentially beneficial for
proper function of the immune system [4, 5, 12]. Psychosocial
stress generated by high demands on productivity, as well as
smoking and alcohol consumption, may be additional
lifestyle-associated risk and severity factors for autoimmune
diseases [13–15]. Finally, lack of physical activity in combi-
nation with excess calorie intake and frequent consumption of
‘fast food’ causes a high prevalence of obesity in developed
societies [16]. Obesity in turn predisposes to metabolic and
cardiovascular disease [17], and it is becoming increasingly
clear that the dietary habits in Western societies (“too much”,
“too fatty”, “too salty”) and a high body mass index (BMI)
also constitute risk factors for autoimmune diseases [18]. In
this review, we briefly summarize the evidence provided by
epidemiological and experimental studies linking nutrition to
autoimmunity. Exploring possible mechanisms, we then dis-
cuss the nexus of nutrition, gut mucosal immunity, and sys-
temic autoimmune responses. Here, T helper cells emerge as
central players linking dietary perturbations to the modulation
of autoimmune pathology.
Nutrients in the Aetiology of Autoimmune Diseases
The association between diet and the risk of developing in-
flammatory autoimmune diseases was proposed as early as
50 years ago [19–21]. Diseases prominently influenced by
nutrition comprise Crohn’s disease and ulcerative colitis
(UC), generally grouped together as IBD, where the patho-
logically affected organ is the gut. Nevertheless, the exact role
of diet as a risk factor in these conditions is less clear-cut.
Numerous foods and food components including dietary milk,
carbohydrates, fats, protein, fiber, fruit, and vegetables have
been studied as potential aetiological factors in IBD, but the
results from the majority of studies have been equivocal and
do not yet support any of these macronutrients as causal
factors [20]. Recent systematic reviews note a possible pre-
disposing role of a diet rich in animal protein and a protective
effect of ω-3 polyunsaturated acids (n3-PUFA) in Crohn’s
disease and UC [22]. Similar to IBD, studies on the role of
cow milk, fruit and berry juices [23], and n3-PUFA [24] in
T1D risk yielded inconsistent results. Interestingly, early
population-based studies in MS, a disease where the influence
of nutrition seems less obvious than in IBD, consistently
suggested dietary traits as risk factors. MS incidence may be
positively associated with the consumption of milk [25], an-
imal fat [26], and meat [27], as well as total energy intake and
resulting obesity [28, 29]. In contrast, diets containing high
amounts of certain polyunsaturated fatty acids and plant fiber
may decrease MS risk [25, 30]. The same pattern of dietary
risk factors was also suggested by studies in RA [21]. Yet,
these epidemiological findings in MS and RA were not cor-
roborated by the majority of more recent case-controlled
studies [19]. Several studies have examined the relationship
between nutrition and the risk of developing Ps, and beneficial
effects were observed, for example, for fish oils [31] or for the
intake of vegetables and fresh fruits [32].
In summary, the body of studies so far addressing nutrition
as an aetiological factor in inflammatory autoimmune diseases
has not firmly verified functional links between dietary mac-
ronutrients and a risk for developing disease. However, the
inconclusive results of epidemiologic studies do not justify
omitting nutrients as influential factors, but rather illustrate the
challenge to detect these on the level of otherwise heteroge-
neous populations. Subjects prone to autoimmunity have
complex individual risk profiles comprised of genetic and
environmental determinants that make their response to nutri-
tional cues diverse [33]. Research testing specific nutrients
and dietary modifications in spontaneous animal models of
autoimmune disease under standardized conditions and a
careful stratification of persons-at-risk in human studies is
therefore required to advance the efforts in identifying dietary
risk factors in autoimmunity.
Obesity as a Risk and Severity Factor in Autoimmunity
Studying the aetiological role of obesity in autoimmunity has
been more fruitful than exploring special diets or single nutri-
ents as predisposing factors. Obesity is defined as abnormal or
excessive fat accumulation that may impair health. The con-
dition is fundamentally caused by excess calorie intake in
relation to calorie expenditure, thus integrating energy intake
changes, dietary composition changes and physical activity
changes that typically occur in the wake of a convenient
lifestyle [34]. According to the WHO, worldwide obesity
has doubled since 1980. WHO global comparable estimates
in 2010 document a mean prevalence of overweight (BMI>
25) or obesity (BMI>30) in 46 % of the US population (aged
15+) as compared to a global mean of 17 % [35]. Obesity is
often accompanied by a condition termedmetabolic syndrome
that is characterized by insulin resistance and high triglyceride
and low high-density lipoprotein (HDL) levels, hypertension,
and systemic inflammation [36].
Obesity and metabolic syndrome predispose individuals to
a plethora of chronic diseases, including inflammatory auto-
immune diseases. For instance, a recent large case-controlled
[29] and a retrospective study [28] demonstrate that a high
BMI and obesity before adulthood are associated with a
higher risk of developing MS. A number of case-controlled
studies robustly also link obesity and metabolic syndrome to
Ps [37] and RA [38]. In particular, the finding that metabolic
syndrome is already present in early-diagnosed RA
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underscores its role as a risk factor [39]. IBD in turn is not
convincingly linked to overweight, obesity, or metabolic syn-
drome on a population level, probably because the symptoms
of the disease can severely compromise food intake [40].
However, the association of obesity and some inflammatory
gut disorders is well documented [41], and alterations in
adipose tissue are noted in Crohn’s disease [42]. Since obesity
and metabolic syndrome are arguably the most consistent
predisposing factors across a large set of inflammatory auto-
immune disease, it seems to be mandatory to prevent exces-
sive fat accumulation in the first place. This again underscores
the need to further investigate dietary factors of the “Western
diet” that are associated with obesity, including animal-
derived fats, refined grains, sugars, and salt.
Mechanisms Linking Western Diet
to Autoimmunity—Fat, Obesity and T Cell Responses
A high-fat diet is a prominent factor promoting obesity, which
leads to excessive accumulation of white adipose tissue (WAT)
and systemic inflammation. WAT is not an inert tissue devoted
solely to energy storage but is now regarded an “endocrine
organ” releasing a plethora of pro-inflammatory mediators such
as TNF-α, IL-6, leptin, resistin, and C-reactive protein [43].
These “adipokines” account for a chronic low-grade systemic
inflammation in obese subjects. Of note, these chronic inflam-
matory signals can have a profound impact on CD4+ T cell
populations, and it has been shown in murine studies that diet-
induced obesity can impact specific fat-resident regulatory T
cells (Treg) and particularly promote a TH17-biased immunity,
partly dependent on IL-6 [44, 45•, 46, 47•]. Moreover, a similar
TH17-biased immune profile in obese people was observed in a
human study [48]. Although the role of IL-17 in obesity seems
to be complex, diet-induced obesity can impact several auto-
immune disease models [49]. It was shown that a high-fat diet
can exacerbate IBD [50], collagen-induced arthritis (CIA) [51],
trinitrobenzenesulfonic acid (TNBS)-induced colitis [44], and
experimental autoimmune encephalomyelitis (EAE, a rodent
model mimicking aspects of MS) [44, 52] (Table 1). Moreover,
published data indicate that paracrine interactions occur between
lymphocytes andWATadjacent to lymphatic tissues [62]. Thus,
it is conceivable that this relationship can influence autoimmune
responses.
Animal studies established leptin, one of the most studied
adipose-derived hormones, as an important link between cal-
orie intake and autoimmune inflammation [63]. Leptin is
critical in the regulation of energy balance and body weight,
but additionally may co-stimulate T cell proliferation and
polarise TH1 responses via direct signaling through T cell-
expressed leptin receptors [64]. Of interest, the levels of
circulating leptin can be sharply reduced by fasting and a
48-h starvation can potently ameliorate severity of a
relapsing-remitting form of EAE [53]. Taken together, the
above findings demonstrate that, on a molecular level, WAT-
derived adipokines and the resultant systemic inflammation
can highly impact T cell responses and thus potentially have a
direct influence on autoimmune diseases.
Mechanisms Linking Western Diet
to Autoimmunity—Sodium Intake and TH17 Cells
Salt (sodium chloride, NaCl) intake varies vastly around the
world, ranging from less than 1 g/day in some indigenous
populations to more than 20 g/day in the Western world and
Japan [65]. The sodium content of processed foods and ‘fast
food’ preferentially consumed in the developed societies can
be more than 100 times higher in comparison to similar
homemade meals [65]. Excess dietary salt intake is already a
well-studied culprit in the development of cardiovascular
disease and stroke [66, 67]. Moreover, experimental studies
in mice highlight a role for T cells as causal players in the
genesis of hypertension and resulting target organ damage
[68–70], suggesting similarities in the aetiology of hyperten-
sive inflammatory autoimmune diseases.
Shapiro and Dinarello noted earlier that osmotic stress can
induce the release of pro-inflammatory cytokines from human
mononuclear cells in culture [71]. Accordingly, the clinical
use of hypertonic saline for plasma expansion is associated
with immune activation [72, 73]. Further investigation of
potential mechanisms underlying this phenomenon demon-
strated that elevated NaCl concentrations enhance T cell re-
sponses on a cellular level, and that p38/MAPK and the
transcription factor nuclear factor of activated T cells 5
(NFAT5) play an integral part of the cellular response to
hyperosmotic environments [74–76].
While the immune-enhancing effect of hypertonicity has
been clearly demonstrated, it is only starting to be unravelled
how dietary salt intake acts as a risk factor for cardiovascular
and autoimmune disease in vivo. This concept involves major
paradigm shifts in the understanding of the body’s sodium and
fluid regulation. Specifically, the steady-state concept of sodi-
um homeostasis dictates that dietary sodium is quantitatively
eliminated via urinary excretion, achieving isotonicity with
constant sodium and water content throughout plasma and
tissues. However, this concept was recently challenged by
observations in laboratory animals and humans [77]. First,
elevated sodium contents were measured in secondary lym-
phatic organs of mice and were proposed as a permissive
environment for NFAT5 activation, which in turn is required
for proper T cell functioning [74]. Second, high-salt diet in
rodents could lead to salt accumulation in the skin-
interstitium, which locally activates macrophages in a
NFAT5-dependent manner. The activated macrophages in turn
affect lymphatics by secretion of vascular endothelial growth
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factor-C (VEGFC) that can inhibit the development of salt-
sensitive hypertension [78, 79•]. Third, by changing salt in-
take under highly controlled conditions, daily sodium excre-
tion revealed periodic sodium storage in humans [80•]. All
together, the classical concept of sodium–water balance has
been challenged by the view that tissue sodium content is
compartmentalized under physiological and pathophysiologi-
cal conditions. Thus, the tissue sodium content seems to exert
a surprising flexibility and can change in response to dietary
intake and may impact immune function.
Based on these findings, effects of elevated NaCl were re-
cently investigated in human T cells and murine EAE [60••].
Elevated NaCl concentrations found locally under physiological
conditions in vivo promoted the in vitro differentiation of murine
and human TH17 cells with a highly pro-inflammatory pheno-
type. This process was dependent on the activation of the os-
motic stress pathway including the serum/glucocorticoid-
regulated kinase 1 (SGK1) [60••]. Of note, mice on a high-salt
diet developed a more severe course of EAE that was associated
with a pronounced TH17 response in vivo, in an SGK1- and IL-
23R-dependent manner [59••, 60••]. However, the exact mech-
anism of how excess dietary salt intake affects CD4+ T cell
responses in vivo and whether other, indirect pathways contrib-
ute to this effect remains to be explored. Since the highest
changes in IL-17-producing cells under non-inflammatory con-
ditions could be detected in gut-associated tissues [59••], salt-
regulated pathways in the gut deserve major attention.
Mechanisms Linking Western Diet
to Autoimmunity— Gut Microbiome and T Cell
Regulation
The intestine is the primary absorption interface for nutrients,
vitamins, and water, and therefore constitutes a premier site to
investigate dietary influences in autoimmune disease. The diges-
tion of proteins, lipids, and carbohydrates in the gut is facilitated
by host enzymes as well as handling by commensal bacteria (the
“gut microbiota”) colonizing the human gut [81]. It is conceiv-
able that the nutritional value of food is influenced by the
composition and operation of a consumer’s gut microbiome,
and that dietary components in turn shape the composition and
functional status of themicrobial community [82•]. For example,
a high-fat diet alters the structure of the microbiome even in the
absence of obesity [83]. The intestinal mucosal immune system
has adapted to tolerate the vast numbers of commensal bacteria,
a balance that involves an intricate two-way communication
mediated by host-derived anti-microbial peptides and sensing
of bacterial-derived molecular patterns [84].
Newmethods to probe themicrobiome, including 16s rRNA
gene pyrosequencing, have fueled research into the composi-
tion and perturbations of the intestinal communities [85]. Such
studies have identified altered gut microbiomes in obesity [86],
T1D [87], and IBD [88]. Gnotobiotic approaches (the rearing of
animals under germ-free conditions, with or without subsequent
exposure to a microbial species or species consortium) have
provided a wealth of information about the functional signifi-
cance of the gut microbiome in autoimmune responses. Mere
presence of intestinal commensal bacteria is a prerequisite for
the development of EAE and IBD in rodents [89••, 90]. Fur-
thermore, clinical signs of actively induced murine EAE can be
ameliorated with the right mixture of orally delivered probiotic
bacteria [91]. Depending on the particular species of gut bacte-
ria, mono-colonization of germ-free mice can either enhance
the differentiation of pro-inflammatory TH17 cells [92•] or
foster the development of Treg [93•, 94••].
An important lesson learned from those studies is that the
gut microbiome can profoundly modulate the extra intestinal
immune responses, in particular the Treg/TH17 balance, and
can “imprint” functional phenotypes in T helper cells. For
instance, the intestinal lamina propria is a site of effector T
cell regulation where an excessive systemic TH17 response
can be locally disarmed by luminal disposal of TH17 cells or
their conversion into IL-10-producing TH17 cells with a
Table 1 Studies testing dietary




induced arthritis, DIC DSS-in-
duced colitis, PUFA polyunsatu-
rated fatty acid, TNBS
trinitrobenzenesulfonic acid
Dietary factor Disease model Ref. Overall effect Putative mechanisms
Calorie restriction EAE [53] Beneficial Curtailment of leptin
Calorie restriction EAE [54] Beneficial Curtailment of leptin
PUFA EAE [55] Beneficial PPAR-γ induction
Olive oil and polyphenols DIC [56] Beneficial PPAR-γ induction
Fish-oil CIA [57] Beneficial Macrophage function
Green tea extract EAE [58] Beneficial NFκB inhibition
High-fat diet IBD [50] Detrimental Unknown
High-fat diet CIA [51] Detrimental TH17 induction
High-fat diet EAE, TNBS Colitis [44] Detrimental TH17 induction
High-salt diet EAE [59••] Detrimental TH17 induction
High-salt diet EAE [60••] Detrimental TH17 induction
Trans fatty acids DIC [61] Detrimental TH17 induction
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regulatory function [95•]. Furthermore, altering the gut micro-
biota by supplementation of probiotic bacteria potently
prevented diet-induced obesity and TH17-biased immunity
despite ad-libitum access to a high calorie “Western diet” in
an IL-10- and Treg-dependent manner. Strikingly, the transfer
of CD4+ T cells was sufficient to confer the same beneficial
effect to recipient mice [45•].
In summary, the gut microbiome is central to maintaining
metabolic balance as well as self-tolerance, and constitutes a
valuable target for dietary intervention and probiotic ap-
proaches. Although conclusive data based on studies in humans
are still sparse, novel reports documenting a central role of T
lymphocytes in integrating nutritional perturbations of the gut
microbiota require further exploration. Here, dietary modula-
tion of T helper cell phenotypes, immunologic memory, and T
cell receptor repertoires are aspects of potential high interest.
Conclusions
Although no definite associations between dietary factors and
autoimmune diseases have so far been firmly established, a
large proportion of patients consider special diets or dietary
supplements as alternative therapeutic measures [19]. While
this is not yet backed by positive phase II or III interventional
trials or consensus recommendations, some aspects may de-
serve special attention. First, symptoms of disease, such as
fatigue in MS, pain and diarrhea in IBD, or the need of acute
medication in T1D, may be considerably affected by food
intake [40]. This may in turn compromise their nutritional
status [96]. Furthermore, a number of immunomodulatory
nutrients such as polyphenols and n3-PUFAs are part of diets
traditionally associated with health benefits, including the
“Mediterranean diet” [97]. Here, diverse foods and food sup-
plements have been tested in interventional studies in various
inflammatory autoimmune diseases. A collection of studies
involving macronutrients in the management of inflammatory
autoimmune disease models is presented in Table 1. Yet, in
humans, large trials are sparse and the recent OFAMS-study
failed to detect any influence n3-PUFA on the course of MS
[98]. In general, it should be considered that the efficacy of
dietary interventions in autoimmune diseases might crucially
depend on how well pathology is controlled by immunomod-
ulatory and anti-inflammatory treatments in first place. None-
theless, numerous positive experimental results across differ-
ent disease entities encourage further exploration of the cellu-
lar and molecular immunological basis underlying nutritional
control of autoimmunity. It is current knowledge that nutri-
tion, the intestinal microbiota, the gut mucosal immune sys-
tem, and autoimmune pathology are deeply intertwined.
The development of further innovative therapies for gut
microbial-dependent immune dysfunctions may also include a
fresh, objective re-assessment of fecal microbial transplants
that more recently have shown extraordinary efficacy in fight-
ing Clostridium difficile infection [99]. Pyrosequencing could
provide information about the exact microbial consortia in
donor feces that are beneficial for a given condition, ultimately
even eliminating the need for this aesthetically unpleasing
procedure. Another unconventional approach could be hel-
minth therapy, the deliberate infection with gut parasitic hook-
worms that exert immunomodulatory effects on the host
[100]. Despite logistic challenges, this kind of treatment is
currently already being tested in MS patients in a phase II trial
(WIRMS study, results due in 2014).
In summary, the links between diet, gut microbiota, T cells,
and autoimmunity are intriguing, and understanding the nexus
of nutrition, metabolism, gut immunology, and systemic im-
mune responses is key to explaining these interactions. Con-
ceivably, effects of nutrition on the gut mucosal immune
system, on sodium and fluid homeostasis, and on the meta-
bolic state of the body could represent additive factors acting
in concert with other (e.g., infectious) triggers in autoimmu-
nity. In fact, the finding that sodium chloride promotes TH17
responses and aggravates EAE illustrates that single nutrition-
al components have the capability to potently modulate auto-
immune responses and inflammation.
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